Cognitive dysfunctions in the course of SARS‑CoV‑2 virus infection, including NeuroCOVID, frontal syndrome and cytokine storm (Review)
- Authors:
- Jakub Sadowski
- Tomasz Klaudel
- Agnieszka Rombel‑Bryzek
- Rafał Jakub Bułdak
-
Affiliations: Student Scientific Society of Clinical Biochemistry and Regenerative Medicine, Department of Clinical Biochemistry and Laboratory Diagnostics, Institute of Medical Sciences, University of Opole, 45‑050 Opole, Poland, Department of Clinical Biochemistry and Laboratory Diagnostics, Institute of Medical Sciences, University of Opole, 45‑050 Opole, Poland - Published online on: May 16, 2024 https://doi.org/10.3892/br.2024.1791
- Article Number: 103
-
Copyright: © Sadowski et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Bodnar B, Patel K, Ho W, Luo JJ and Hu W: Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J Med Virol. 93:1983–1998. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G and David AS: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 7:611–627. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Moldofsky H and Patcai J: Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 11(37)2011.PubMed/NCBI View Article : Google Scholar | |
|
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 367:1260–1263. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rombel-Bryzek A, Miller A and Witkowska D: Thermodynamic analysis of the interactions between human ACE2 and spike RBD of Betacoronaviruses (SARS-CoV-1 and SARS-CoV-2). FEBS Open Bio. 13:174–184. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ and Baghi HB: SARS-CoV-2: Receptor and co-receptor Tropism Probability. Curr Microbiol. 79(133)2022.PubMed/NCBI View Article : Google Scholar | |
|
Lim S, Zhang M and Chang TL: ACE2-independent alternative receptors for SARS-CoV-2. Viruses. 14(2535)2022.PubMed/NCBI View Article : Google Scholar | |
|
Strollo R and Pozzilli P: DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19? Diabetes Metab Res Rev. 36(e3330)2020.PubMed/NCBI View Article : Google Scholar | |
|
Raha AA, Chakraborty S, Henderson J, Mukaetova-Ladinska E, Zaman S, Trowsdale J and Raha-Chowdhury R: Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology. Biosci Rep. 40(BSR20203092)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kotani N and Nakano T: Candidate screening of host cell membrane proteins involved in SARS-CoV-2 entry. bioRxiv: 2020.09.09.289488, 2020. | |
|
Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, Bouysset C, Pirastu N, Dibattista M, et al: More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 45:609–622. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cure E and Cumhur Cure M: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes Metab Syndr. 14:349–350. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Long B, Brady WJ, Koyfman A and Gottlieb M: Cardiovascular complications in COVID-19. Am J Emerg Med. 38:1504–1507. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mankad K, Perry MD, Mirsky DM and Rossi A: COVID-19: A primer for neuroradiologists. Neuroradiology. 62:647–648. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Saleki K, Banazadeh M, Saghazadeh A and Rezaei N: The involvement of the central nervous system in patients with COVID-19. Rev Neurosci. 31:453–456. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, Bayat AH, Fathi M, Vakili K, Alizadeh R, Rezaeimirghaed O, Hajiesmaeili M, Ramezani M, et al: Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem Neurosci. 11:1909–1913. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Samaranayake LP, Fakhruddin KS and Panduwawala C: Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): A systematic review. Acta Odontol Scand. 78:467–473. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shahbazi R, Yasavoli-Sharahi H, Alsadi N, Ismail N and Matar C: Probiotics in treatment of viral respiratory infections and neuroinflammatory disorders. Molecules. 25(4891)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ferguson AV: Circumventricular organs: integrators of circulating signals controlling hydration, energy balance, and immune function. In: Neurobiology of Body Fluid Homeostasis: Transduction and Integration. De Luca LA, Menani JV and Johnson AK (eds.) CRC Press/Taylor & Francis, Boca Raton (FL), 2014. | |
|
Kim J, Alejandro B, Hetman M, Hattab EM, Joiner J, Schroten H, Ishikawa H and Chung DH: Zika virus infects pericytes in the choroid plexus and enters the central nervous system through the blood-cerebrospinal fluid barrier. PLoS Pathog. 16(e1008204)2020.PubMed/NCBI View Article : Google Scholar | |
|
Alam SB, Willows S, Kulka M and Sandhu JK: Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur J Neurol. 27:2348–2360. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang F, Wu X, Gao J, Li Y, Zhu Y and Fang Y: The relationship of olfactory function and clinical traits in major depressive disorder. Behav Brain Res. 386(112594)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yahiaoui-Doktor M, Luck T, Riedel-Heller SG, Loeffler M, Wirkner K and Engel C: Olfactory function is associated with cognitive performance: Results from the population-based LIFE-adult-study. Alzheimers Res Ther. 11(43)2019.PubMed/NCBI View Article : Google Scholar | |
|
Li YC, Bai WZ and Hashikawa T: The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 92:552–555. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li H, Xue Q and Xu X: Involvement of the nervous system in SARS-CoV-2 infection. Neurotox Res. 38:1–7. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Andriuta D, Roger PA, Thibault W, Toublanc B, Sauzay C, Castelain S, Godefroy O and Brochot E: COVID-19 encephalopathy: Detection of antibodies against SARS-CoV-2 in CSF. J Neurol. 267:2810–2811. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sinanović O, Muftić M and Sinanović S: COVID-19 pandemia: Neuropsychiatric comorbidity and consequences. Psychiatr Danub. 32:236–244. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Xiang P, Xu X, Lu X, Gao L, Wang H, Li Z, Xiong H, Li R, Xiong Y, Pu L, et al: Case report: Identification of SARS-CoV-2 in cerebrospinal fluid by ultrahigh-depth sequencing in a patient with coronavirus disease 2019 and neurological dysfunction. Front Med (Lausanne). 8(629828)2021.PubMed/NCBI View Article : Google Scholar | |
|
Cebrián J, Gonzalez-Martinez A, García-Blanco MJ, Celdrán-Vivancos D, Palacios EL, Reig-Roselló G, Casado-Fernández L, Vivancos J and Gago-Veiga AB: Headache and impaired consciousness level associated with SARS-CoV-2 in CSF: A case report. Neurology. 95:266–268. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fadakar N, Ghaemmaghami S, Masoompour SM, Shirazi Yeganeh B, Akbari A, Hooshmandi S and Ostovan VR: A first case of acute cerebellitis associated with coronavirus disease (COVID-19): A case report and literature review. Cerebellum. 19:911–914. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kremer S, Lersy F, de Sèze J, Ferré JC, Maamar A, Carsin-Nicol B, Collange O, Bonneville F, Adam G, Martin-Blondel G, et al: Brain MRI findings in severe COVID-19: A retrospective observational study. Radiology. 297:E242–E251. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Virhammar J, Kumlien E, Fällmar D, Frithiof R, Jackmann S, Sköld MK, Kadir M, Frick J, Lindeberg J, Olivero-Reinius H, et al: Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology. 95:445–449. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K and Akdis CA: Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 75:1564–1581. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tang SW, Helmeste D and Leonard B: Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation. Acta Neuropsychiatr. 33:165–177. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Elieh Ali Komi D, Wöhrl S and Bielory L: Mast cell biology at molecular level: A comprehensive review. Clin Rev Allergy Immunol. 58:342–365. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cabrera-Pastor A, Llansola M, Montoliu C, Malaguarnera M, Balzano T, Taoro-Gonzalez L, García-García R, Mangas-Losada A, Izquierdo-Altarejos P, Arenas YM, et al: Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications. Acta Physiol (Oxf). 226(e13270)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Ahmed ME, Selvakumar GP, Thangavel R, Dhaliwal AS, Dubova I, Mentor S, Premkumar K, Saeed D, Zahoor H, et al: Brain injury-mediated neuroinflammatory response and Alzheimer's disease. Neuroscientist. 26:134–155. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Mentor S, Thangavel R, Ahmed ME, Selvakumar GP, Raikwar SP, Dubova I, Zaheer S, Iyer SS and Zaheer A: Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer's disease. Front Cell Neurosci. 13(54)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, Zaheer SA, Iyer SS, Burton C, James D and Zaheer A: COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 26:402–414. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kustrimovic N, Marino F and Cosentino M: Peripheral immunity, immunoaging and neuroinflammation in Parkinson's disease. Curr Med Chem. 26:3719–3753. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Magrone T, Magrone M, Russo MA and Jirillo E: Peripheral immunosenescence and central neuroinflammation: A dangerous liaison-A dietary approach. Endocr Metab Immune Disord Drug Targets. 20:1391–1411. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC: Effect of stress on neuroimmune processes. Clin Ther. 42:1007–1014. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Debuc B and Smadja DM: Is COVID-19 a new hematologic disease? Stem Cell Rev Rep. 17:4–8. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wilson MP and Jack AS: Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature. Clin Neurol Neurosurg. 193(105866)2020.PubMed/NCBI View Article : Google Scholar | |
|
Nile SH, Nile A, Qiu J, Li L, Jia X and Kai G: COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 53:66–70. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Karamloo F and König R: SARS-CoV-2 immunogenicity at the crossroads. Allergy. 75:1822–1824. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC: COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. 46:306–308. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R and Conti P: Mast cells contribute to coronavirus-induced inflammation: New anti-inflammatory strategy. J Biol Regul Homeost Agents. 34:9–14. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Connell NT, Battinelli EM and Connors JM: Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost. 18:E1–E2. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Markus HS and Brainin M: COVID-19 and stroke-A global world stroke organization perspective. Int J Stroke. 15:361–364. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Khalili N, Haseli S, Bahrami-Motlagh H, Keshavarz E, Khalili N, Langroudi TF, Khameneh A and Taheri MS: Neurologic involvement in COVID-19: Radiologists' perspective. Acad Radiol. 27:1051–1053. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Qiu H, Wu J, Hong L, Luo Y, Song Q and Chen D: Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis. 20:689–696. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Xie B and Hashimoto K: Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun. 87:59–73. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z and Zhang Z: D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 18:1324–1329. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Connors JM and Levy JH: COVID-19 and its implications for thrombosis and anticoagulation. Blood. 135:2033–2040. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D, Luqmani A, Jenkins IH, Nicholas R, Jones B and Everitt A: COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflammation. 7(e789)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ogier M, Andéol G, Sagui E and Dal Bo G: How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav Immun Health. 5(100081)2020.PubMed/NCBI View Article : Google Scholar | |
|
Park CL, Russell BS, Fendrich M, Finkelstein-Fox L, Hutchison M and Becker J: Americans' COVID-19 stress, coping, and adherence to CDC guidelines. J Gen Intern Med. 35:2296–2303. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Baig AM, Khaleeq A, Ali U and Syeda H: Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 11:995–998. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Pineton de Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, Mathian A, Hekimian G and Combes A: High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? J Intern Med. 289:422–424. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Finsterer J and Stollberger C: Update on the neurology of COVID-19. J Med Virol. 92:2316–2318. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Heneka MT, Golenbock D, Latz E, Morgan D and Brown R: Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 12(69)2020.PubMed/NCBI View Article : Google Scholar | |
|
Leonardi M, Padovani A and McArthur JC: Neurological manifestations associated with COVID-19: A review and a call for action. J Neurol. 267:1573–1576. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, Suárez-Pérez J, Jiménez-Hernández MD, Moya-Molina MÁ, Oliver-Martos B, et al: Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurologia (Engl Ed). 35:245–251. 2020.PubMed/NCBI View Article : Google Scholar : (In English, Spanish). | |
|
Parrella E, Porrini V, Benarese M and Pizzi M: The role of mast cells in stroke. Cells. 8(437)2019.PubMed/NCBI View Article : Google Scholar | |
|
Bougakov D, Podell K and Goldberg E: Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol. 58:564–575. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ritchie K, Chan D and Watermeyer T: The cognitive consequences of the COVID-19 epidemic: Collateral damage? Brain Commun. 2(fcaa069)2020.PubMed/NCBI View Article : Google Scholar | |
|
Forkel SJ, Friedrich P, Thiebaut de Schotten M and Howells H: White matter variability, cognition, and disorders: A systematic review. Brain Struct Funct. 227:529–544. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Krause-Utz A, Oei NYL, Niedtfeld I, Bohus M, Spinhoven P, Schmahl C and Elzinga BM: Influence of emotional distraction on working memory performance in borderline personality disorder. Psychol Med. 42:2181–2192. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Dinakaran D, Manjunatha N, Naveen Kumar C and Suresh BM: Neuropsychiatric aspects of COVID-19 pandemic: A selective review. Asian J Psychiatr. 53(102188)2020.PubMed/NCBI View Article : Google Scholar | |
|
Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y, et al: Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 218(e20202135)2021.PubMed/NCBI View Article : Google Scholar | |
|
Jacob F, Pather SR, Huang WK, Zhang F, Wong SZH, Zhou H, Cubitt B, Fan W, Chen CZ, Xu M, et al: Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell. 27:937–950.e9. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mesci P, Macia A, Saleh A, Martin-Sancho L, Yin X, Snethlage C, Avansini S, Chanda SK and Muotri A: Sofosbuvir protects human brain organoids against SARS-CoV-2. bioRxiv: 2020.05.30.125856, 2020. | |
|
Ramani A, Müller L, Ostermann PN, Gabriel E, Abida-Islam P, Müller-Schiffmann A, Mariappan A, Goureau O, Gruell H, Walker A, et al: SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 39(e106230)2020.PubMed/NCBI View Article : Google Scholar | |
|
Oliveira R, Sotero FD and Teodoro T: NeuroCOVID: Critical review of neuropsychiatric manifestations of SARS-CoV-2 infection. Ir J Med Sci. 190:851–852. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al: Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77:683–690. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Banerjee D and Viswanath B: Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian J Psychiatry. 54(102350)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Long X, Zhang Q, Fang X, Fang F, Lv X, Zhang D, Sun Y, Li N, Hu S, et al: Emerging evidence for neuropsycho-consequences of COVID-19. Curr Neuropharmacol. 19:92–96. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Sozzi M, Algeri L, Corsano M, Crivelli D, Daga MA, Fumagalli F, Gemignani P, Granieri MC, Inzaghi MG, Pala F, et al: Neuropsychology in the times of COVID-19 the role of the psychologist in taking charge of patients with alterations of cognitive functions. Front Neurol. 11(573207)2020.PubMed/NCBI View Article : Google Scholar | |
|
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, et al: Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 382:2268–2270. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C and Hu S: The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 129:98–102. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Vinkers CH, van Amelsvoort T, Bisson JI, Branchi I, Cryan JF, Domschke K, Howes OD, Manchia M, Pinto L, de Quervain D, et al: Stress resilience during the coronavirus pandemic. Eur Neuropsychopharmacol. 35:12–16. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Steenblock C, Todorov V, Kanczkowski W, Eisenhofer G, Schedl A, Wong ML, Licinio J, Bauer M, Young AH, Gainetdinov RR and Bornstein SR: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry. 25:1611–1617. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ye Q, Wang B and Mao J: The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect. 80:607–613. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Ahmed ME, Selvakumar GP, Thangavel R, Raikwar SP, Zaheer SA, Iyer SS, Burton C, James D and Zaheer A: Psychological stress-induced immune response and risk of Alzheimer's disease in veterans from operation enduring freedom and operation iraqi freedom. Clin Ther. 42:974–982. 2020.PubMed/NCBI View Article : Google Scholar | |
|
De Felice FG, Tovar-Moll F, Moll J, Munoz DP and Ferreira ST: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 43:355–357. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sheraton M, Deo N, Kashyap R and Surani S: A review of neurological complications of COVID-19. Cureus. 12(e8192)2020.PubMed/NCBI View Article : Google Scholar | |
|
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, et al: Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol. 277:2251–2261. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Barlow A, Landolf KM, Barlow B, Yeung SYA, Heavner JJ, Claassen CW and Heavner MS: Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019. Pharmacotherapy. 40:416–437. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gigante A, Aquili A, Farinelli L, Caraffa A, Ronconi G, Enrica Gallenga C, Tetè G, Kritas SK and Conti P: Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19. Med Hypotheses. 143(109856)2020.PubMed/NCBI View Article : Google Scholar | |
|
Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R and Kritas SK: How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 34:333–338. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, de Sire A, Negrini S and Zapparoli L: Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch Phys Med Rehabil. 102:155–158. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Verkhratsky A, Li Q, Melino S, Melino G and Shi Y: Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct. 15(28)2020.PubMed/NCBI View Article : Google Scholar | |
|
Minihan E, Gavin B, Kelly BD and McNicholas F: COVID-19, mental health and psychological first aid. Ir J Psychol Med. 37:259–263. 2020.PubMed/NCBI View Article : Google Scholar |
